Patient-specific dosimetry of (99m)Tc-HYNIC-Tyr(3)-Octreotide in children

BACKGROUND: Technetium-99m-hydrazinonicotinamide-Tyr(3)-octreotide ((99m)Tc-HYNIC-TOC) is recognized as a promising radiopharmaceutical for diagnosing neuroendocrine tumors (NETs). However, (99m)Tc-HYNIC-TOC dosimetry has been investigated only for adults. As pediatric radionuclide therapies become...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Xinchi, Birkenfeld, Bozena, Piwowarska-Bilska, Hanna, Celler, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640560/
https://www.ncbi.nlm.nih.gov/pubmed/29030760
http://dx.doi.org/10.1186/s40658-017-0191-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640560/
https://www.ncbi.nlm.nih.gov/pubmed/29030760
http://dx.doi.org/10.1186/s40658-017-0191-6

Ejemplares similares